{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T17:30:12Z","timestamp":1782149412914,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"FCT","award":["SFRH\/BD\/89582\/2012"],"award-info":[{"award-number":["SFRH\/BD\/89582\/2012"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.02.021","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T01:32:13Z","timestamp":1487727133000},"page":"316-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation"],"prefix":"10.1016","volume":"117","author":[{"given":"Francisco M.","family":"Mouro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia L.","family":"Batalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana G.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana E.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younis","family":"Baqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa V.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim A.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Sebasti\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.02.021_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(01)00873-1","article-title":"Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2","volume":"416","author":"Aceto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tips.2008.10.008","article-title":"Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia","volume":"30","author":"Akopian","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib3","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1289-05.2005","article-title":"Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase a site in striatal projection neurons","volume":"25","author":"Andersson","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","article-title":"The novel object recognition memory: neurobiology, test procedure, and its modifications","volume":"13","author":"Antunes","year":"2012","journal-title":"Cogn. Process"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib5","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study","volume":"325","author":"Arseneault","year":"2002","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib6","series-title":"Methods of Behavior Analysis in Nueroscience","article-title":"Anxiety-related behaviors in mice","author":"Bailey","year":"2009"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2012.8","article-title":"Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation","volume":"18","author":"Batalha","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.2044-8295.1958.tb00632.x","article-title":"Determination of emotionality in the rat. I. Situational factors","volume":"49","author":"Broadhurst","year":"1957","journal-title":"Br. J. Psychol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.2044-8295.1958.tb00632.x","article-title":"Determinants of emotionality in the rat. II. Antecedent factors","volume":"49","author":"Broadhurst","year":"1958","journal-title":"Br. J. Psychol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hipo.20858","article-title":"Recognition memory: material, processes, and substrates","volume":"20","author":"Brown","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib12","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10519-012-9543-0","article-title":"Are voluntary wheel running and open-field behavior correlated in Mice? Different answers from comparative and artificial selection approaches","volume":"42","author":"Careau","year":"2012","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/pmt.14.49","article-title":"Re-branding cannabis: the next generation of chronic pain medicine?","volume":"5","author":"Carter","year":"2015","journal-title":"Pain Manag."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0031-9384(04)00302-6","article-title":"Cannabinoid (CB)1 receptor antagonist, AM251, causes a sustained reduction of daily food intake in the rat","volume":"82","author":"Chambers","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib16","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J.\u00a0Neurosci"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2004.11.014","article-title":"Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001","volume":"79","author":"Chen","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/jnc.13421","article-title":"Striatal adenosine-cannabinoid receptor interactions in rats overexpressing adenosine A2A receptors","volume":"136","author":"Chiodi","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib19","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1073\/pnas.0915059107","article-title":"Plastic modifications induced by object recognition memory processing","volume":"107","author":"Clarke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.nlm.2008.04.009","article-title":"Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory","volume":"90","author":"Clarke","year":"2008","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib21","first-page":"1","article-title":"Overexpression of adenosine A2A receptors in rats: effects on depression, locomotion, and anxiety","volume":"5","author":"Coelho","year":"2014","journal-title":"Front. Psych."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/YCO.0b013e328361eae5","article-title":"Changes in cannabis use among young people: impact on mental health","volume":"26","author":"Copeland","year":"2013","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.expneurol.2007.11.013","article-title":"Adenosine A2A receptor blockade prevents memory dysfunction caused by \u03b2-amyloid peptides but not by scopolamine or MK-801","volume":"210","author":"Cunha","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0006-8993(94)91066-9","article-title":"Evidence for functionally important adenosine A2a receptors in the rat hippocampus","volume":"649","author":"Cunha","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1471-4159.1994.63010207.x","article-title":"Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus","volume":"63","author":"Cunha","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11302-013-9364-5","article-title":"A1R-A2AR heteromers coupled to Gs and Gi\/0 proteins modulate GABA transport into astrocytes","volume":"9","author":"Crist\u00f3v\u00e3o-Ferreira","year":"2013","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0024-3205(96)00544-9","article-title":"Adenosine and neuronal plasticity","volume":"60","author":"de Mendon\u00e7a","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib28","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.neuropharm.2012.01.030","article-title":"Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects","volume":"62","author":"de Lago","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(96)00746-7","article-title":"Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene","volume":"317","author":"De Sarro","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib30","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1124\/mol.106.024661","article-title":"CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action","volume":"70","author":"Degroot","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib31","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hipo.20894","article-title":"Enhancement of AMPA currents and GluR1 membrane expression through PKA-coupled adenosine A(2A) receptors","volume":"22","author":"Dias","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib32","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1523\/JNEUROSCI.0372-06.2006","article-title":"Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission","volume":"26","author":"Domenici","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.0953-816x.2001.01771.x","article-title":"In\u00a0vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261","volume":"14","author":"El Yacoubi","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbr.2009.12.036","article-title":"One-trial object recognition in rats and mice: methodological and theoretical issues","volume":"215","author":"Ennaceur","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A\u00a0new one-trial test for neurobiological studies of memory in rats. 1: behavioural data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/bph.12492","article-title":"The influence of cannabinoids on generic traits of neurodegeneration","volume":"171","author":"Fagan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib37","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.2010.00723.x","article-title":"Adenosine-cannabinoid receptor interactions. Implications for striatal function","volume":"160","author":"Ferr\u00e9","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/bph.12970","article-title":"Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission","volume":"172","author":"Ferreira","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuropharm.2016.04.009","article-title":"Toll-like receptor signalling as a cannabinoid target in multiple sclerosis","volume":"113","author":"Fitzpatrick","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib40","series-title":"Adenosine A2A Receptor Modulation of Hippocampal CA3-CA1 Synapse Plasticity during Associative Learning in Behaving Mice Neuropsychopharmacology","first-page":"1865","volume":"vol. 34","author":"Fontinha","year":"2009"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib41","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2012.01.037","article-title":"Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD","volume":"148","author":"Han","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib43","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1021\/jo0358574","article-title":"Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease","volume":"69","author":"Hockemeyer","year":"2004","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1523\/JNEUROSCI.4920-09.2010","article-title":"Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors","volume":"30","author":"Hoffman","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib45","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.0b013e318212ab0c","article-title":"Effects of cannabis on cognitive function in patients with multiple sclerosis","volume":"76","author":"Honarmand","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib47","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.1423088112","article-title":"Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress","volume":"112","author":"Kaster","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0306-4522(02)00080-5","article-title":"Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition","volume":"112","author":"Lopes","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neuropharm.2015.04.034","article-title":"An animal model of female adolescent cannabinoid exposure elicits a long-lasting deficit in presynaptic long-term plasticity","volume":"99","author":"Lovelace","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/epi.12610","article-title":"The case for medical marijuana in epilepsy","volume":"55","author":"Maa","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib51","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrn3846","article-title":"Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies","volume":"15","author":"Maccarrone","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-4159.2010.07101.x","article-title":"Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission","volume":"116","author":"Martire","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib53","doi-asserted-by":"crossref","first-page":"18492","DOI":"10.1523\/JNEUROSCI.1828-13.2013","article-title":"Antagonistic interaction between adenosine A2A receptors and Na+\/K+-ATPase-\u03b12 controlling glutamate uptake in astrocytes","volume":"33","author":"Matos","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00213-005-2171-0","article-title":"The cannabinoid CB1 antagonist AM251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats","volume":"180","author":"McLaughlin","year":"2005","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-3565(24)37372-0","article-title":"Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat","volume":"285","author":"Monopoli","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib56","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pbio.0050269","article-title":"Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice","volume":"5","author":"Monory","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3930","article-title":"Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory","volume":"18","author":"Orr","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib58","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib59","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1111\/j.1476-5381.2011.01554.x","article-title":"Combined effects of THC and caffeine on working memory in rats","volume":"165","author":"Panlilio","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib60","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jtbi.2014.04.024","article-title":"Modeling the functional network of primary intercellular Ca2+ wave propagation in astrocytes and its application to study drug effects","volume":"356C","author":"Pires","year":"2014","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib63","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1358\/dnp.2003.16.2.740246","article-title":"Participation of adenosine receptors in neuroprotection","volume":"16","author":"Ribeiro","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.083","article-title":"Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review","volume":"101","author":"Rivera-Oliver","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib66","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hipo.22392","article-title":"Synaptic mechanisms of adenosine A2A receptor-mediated hyperexcitability in the hippocampus","volume":"25","author":"Rombo","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib67","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/cercor\/bhu288","article-title":"Adenosine A1 receptor suppresses tonic GABAA receptor currents in hippocampal pyramidal cells and in a defined subpopulation of interneurons","volume":"26","author":"Rombo","year":"2016","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0269881111408958","article-title":"The endocannabinoid system in anxiety, fear memory and habituation","volume":"26","author":"Ruehle","year":"2012","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib69","first-page":"11","article-title":"The effect of cannabis use on memory function: an update","volume":"4","author":"Schoeler","year":"2013","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/157015909789152128","article-title":"Tuning and fine-tuning of synapses with adenosine","volume":"7","author":"Sebasti\u00e3o","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib71","doi-asserted-by":"crossref","first-page":"872684","DOI":"10.1155\/2015\/872684","article-title":"The combined inhibitory effect of the adenosine A1 and cannabinoid CB1 receptors on cAMP accumulation in the hippocampus is additive and independent of A1 receptor desensitization","volume":"2015","author":"Serpa","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib72","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuint.2015.06.005","article-title":"Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus","volume":"87","author":"Serpa","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2009.09.020","article-title":"Cannabinoid CB(1) and adenosine A(1) receptors independently inhibit hippocampal synaptic transmission","volume":"623","author":"Serpa","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874473710801010081","article-title":"The chronic effects of cannabis on memory in humans: a review","volume":"1","author":"Solowij","year":"2008","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib75","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/npp.2010.179","article-title":"Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of \u03949-tetrahydrocannabinol on spatial memory","volume":"36","author":"Sousa","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib76","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0269881107073199","article-title":"The open field test: reinventing the wheel","volume":"21","author":"Stanford","year":"2007","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib77","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbr.2008.02.029","article-title":"Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats","volume":"190","author":"Suenaga","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2012.04.051","article-title":"Adenosine A(2A)-cannabinoid CB(1) receptor interaction: an integrative mechanism in striatal glutamatergic neurotransmission","volume":"1476","author":"Tebano","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib79","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1523\/JNEUROSCI.23-28-09374.2003","article-title":"Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action","volume":"23","author":"Tzavara","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib80","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0091-6773(76)90901-9","article-title":"Open-field behavior in muroid rodents","volume":"17","author":"Wilson","year":"1976","journal-title":"Behav. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib81","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/npp.2009.31","article-title":"Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol","volume":"34","author":"Wise","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.021_bib82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbr.2014.09.050","article-title":"Neural circuitry for rat recognition memory","volume":"285","author":"Warburton","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib83","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1523\/JNEUROSCI.0726-06.2006","article-title":"Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens","volume":"26","author":"Xi","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00210-007-0135-0","article-title":"Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists","volume":"375","author":"Yang","year":"2007","journal-title":"Naunyn. Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.021_bib85","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.neuroscience.2007.08.037","article-title":"Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus","volume":"151","author":"Yim","year":"2008","journal-title":"Neuroscience"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:50:03Z","timestamp":1758437403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":85,"alternative-id":["S0028390817300758"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic and acute adenosine A2A receptor blockade prevents long-term episodic memory disruption caused by acute cannabinoid CB1 receptor activation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}